FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...